We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
ESC 2024 - LDL-c, hsCRP, and Lp(a) predict 5-year to 10-year CVD risk, but do these biomarkers predict lifetime risk? The Women’s Health Study assessed the prognostic value of these 3 biomarkers for assessing long-term CVD risk using a single blood sample from 1993 in women.
This video was recorded during the ESC Congress 2024 in London, UK.
Paul M. Ridker, MD is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, US.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read the paper in N J Engl Med.
Release date: 2 September 2024
ESC 2024 - LDL-c, hsCRP, and Lp(a) predict 5-year to 10-year CVD risk, but do these biomarkers predict lifetime risk? The Women’s Health Study assessed the prognostic value of these 3 biomarkers for assessing long-term CVD risk using a single blood sample from 1993 in women.
This video was recorded during the ESC Congress 2024 in London, UK.
Paul M. Ridker, MD is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, US.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read the paper in N J Engl Med.
Release date: 2 September 2024
Stay current with the best on medical education
